160 related articles for article (PubMed ID: 37489745)
1. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
Butow PN; Turner J; Gilchrist J; Sharpe L; Smith AB; Fardell JE; Tesson S; O'Connell R; Girgis A; Gebski VJ; Asher R; Mihalopoulos C; Bell ML; Zola KG; Beith J; Thewes B
J Clin Oncol; 2017 Dec; 35(36):4066-4077. PubMed ID: 29095681
[TBL] [Abstract][Full Text] [Related]
3. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
[TBL] [Abstract][Full Text] [Related]
4. ConquerFear-group: Feasibility study with pilot results of a psychological intervention for fear of cancer recurrence delivered in groups.
Tauber NM; Zachariae R; Jensen AB; Thewes B; Skyt I; Elkjaer E; Butow PN; O'Toole MS
Psychooncology; 2022 Jan; 31(1):30-38. PubMed ID: 34289212
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors.
Ng DWL; Fielding R; Tsang C; Ng C; Chan J; Or A; Kong IWM; Tang JWC; Li WWY; Chang ATY; Foo CC; Kwong A; Ng SS; Suen D; Chan M; Chun OK; Chan KKL; Butow PN; Lam WWT
BMJ Open; 2023 Jan; 13(1):e065075. PubMed ID: 36669845
[TBL] [Abstract][Full Text] [Related]
6. Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.
Sharpe L; Turner J; Fardell JE; Thewes B; Smith AB; Gilchrist J; Beith J; Girgis A; Tesson S; Day S; Grunewald K; Butow P;
J Cancer Surviv; 2019 Oct; 13(5):695-702. PubMed ID: 31347010
[TBL] [Abstract][Full Text] [Related]
7. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
[TBL] [Abstract][Full Text] [Related]
8. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.
Tomei C; Lebel S; Maheu C; Lefebvre M; Harris C
Support Care Cancer; 2018 Aug; 26(8):2751-2762. PubMed ID: 29500582
[TBL] [Abstract][Full Text] [Related]
9. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
Johns SA; Stutz PV; Talib TL; Cohee AA; Beck-Coon KA; Brown LF; Wilhelm LR; Monahan PO; LaPradd ML; Champion VL; Miller KD; Giesler RB
Cancer; 2020 Jan; 126(1):211-218. PubMed ID: 31539169
[TBL] [Abstract][Full Text] [Related]
10. No effect of CBT-based online self-help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial.
van Helmondt SJ; van der Lee ML; van Woezik RAM; Lodder P; de Vries J
Psychooncology; 2020 Jan; 29(1):86-97. PubMed ID: 31595627
[TBL] [Abstract][Full Text] [Related]
11. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
[TBL] [Abstract][Full Text] [Related]
12. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer.
van Helmondt SJ; van der Lee ML; de Vries J
BMC Cancer; 2016 Jul; 16():527. PubMed ID: 27455846
[TBL] [Abstract][Full Text] [Related]
13. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence.
Butow PN; Bell ML; Smith AB; Fardell JE; Thewes B; Turner J; Gilchrist J; Beith J; Girgis A; Sharpe L; Shih S; Mihalopoulos C;
BMC Cancer; 2013 Apr; 13():201. PubMed ID: 23617696
[TBL] [Abstract][Full Text] [Related]
14. Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivors.
Lyhne JD; Smith A'B; Frostholm L; Fink P; Jensen LH
BMC Cancer; 2020 Mar; 20(1):223. PubMed ID: 32178640
[TBL] [Abstract][Full Text] [Related]
15. Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer.
Maheu C; Hébert M; Louli J; Yao TR; Lambert S; Cooke A; Black A; Kyriacou J
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1172. PubMed ID: 32721129
[TBL] [Abstract][Full Text] [Related]
16. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials.
Vachon E; Krueger E; Champion VL; Haggstrom DA; Cella D; Cohee AA
Psychooncology; 2021 Mar; 30(3):279-286. PubMed ID: 33022832
[TBL] [Abstract][Full Text] [Related]
17. Towards the validation of a new, blended theoretical model of fear of cancer recurrence.
Lebel S; Maheu C; Tomei C; Bernstein LJ; Courbasson C; Ferguson S; Harris C; Jolicoeur L; Lefebvre M; Muraca L; Ramanakumar AV; Singh M; Parrott J; Figueiredo D
Psychooncology; 2018 Nov; 27(11):2594-2601. PubMed ID: 30180279
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
[TBL] [Abstract][Full Text] [Related]
19. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
van de Wal M; Thewes B; Gielissen M; Speckens A; Prins J
J Clin Oncol; 2017 Jul; 35(19):2173-2183. PubMed ID: 28471726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
